SCHEMBL30217608

SCHEMBL30217608

COc1cnc2c(C(=O)Nc3cc(F)c4nc(C)cn4c3)ccc(N3CCN(C(=O)OC(C)(C)C)CC3)c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PTPN11 Q06124 1/20 0.42
▸ THRB P10828 1/20 0.40
▸ ALK Q9UM73 2/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ BACE1 P56817 2/20 0.38
▸ F2RL3 Q96RI0 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ SMPD3 Q9NY59 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ GALR2 O43603 1/20 0.36
▸ GALR1 P47211 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ GPR35 Q9HC97 1/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25095938 1.00 MAPT (0.44) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL25095913 0.98 MAPT (0.44) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL30217607 0.98 MAPT (0.44) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL30217776 0.93 PTPN11 (0.45) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL25097071 0.93 PTPN11 (0.45) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL25096320 0.91 PTPN11 (0.46) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL30217787 0.91 PTPN11 (0.46) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL30312613 0.90 PTPN11 (0.44) MAPTMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL25095943 0.89 KDM4E (0.41) MAPTMEN1KMT2APOLB
SCHEMBL25095784 0.89 BACE1 (0.40) MAPTMEN1TSHRKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4395891-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2024-07-10 — — EP disclosed
CN-118234724-A Compounds and methods for modulating splicing 雷密克斯医疗公司 2024-06-21 — — CN disclosed
WO-2023034811-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 — — WO disclosed
Send feedback